These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 31257576)

  • 1. Neuropilin-2 contributes to tumor progression in preclinical models of small intestinal neuroendocrine tumors.
    Bollard J; Patte C; Radkova K; Massoma P; Chardon L; Valantin J; Gadot N; Goddard I; Vercherat C; Hervieu V; Gouysse G; Poncet G; Scoazec JY; Walter T; Roche C
    J Pathol; 2019 Nov; 249(3):343-355. PubMed ID: 31257576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropilin-2 mediated β-catenin signaling and survival in human gastro-intestinal cancer cell lines.
    Samuel S; Gaur P; Fan F; Xia L; Gray MJ; Dallas NA; Bose D; Rodriguez-Aguayo C; Lopez-Berestein G; Plowman G; Bagri A; Sood AK; Ellis LM
    PLoS One; 2011; 6(10):e23208. PubMed ID: 22028766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EZH2 presents a therapeutic target for neuroendocrine tumors of the small intestine.
    Barazeghi E; Hellman P; Norlén O; Westin G; Stålberg P
    Sci Rep; 2021 Nov; 11(1):22733. PubMed ID: 34815475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor microenvironment confers mTOR inhibitor resistance in invasive intestinal adenocarcinoma.
    Fujishita T; Kojima Y; Kajino-Sakamoto R; Taketo MM; Aoki M
    Oncogene; 2017 Nov; 36(46):6480-6489. PubMed ID: 28759045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropilin-1 (NRP-1) upregulated by IL-6/STAT3 signaling contributes to invasion in pancreatic neuroendocrine neoplasms.
    Yang Y; Yang L; Li Y
    Hum Pathol; 2018 Nov; 81():192-200. PubMed ID: 30420046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropilin-1 suppresses tumorigenic properties in a human pancreatic adenocarcinoma cell line lacking neuropilin-1 coreceptors.
    Gray MJ; Wey JS; Belcheva A; McCarty MF; Trevino JG; Evans DB; Ellis LM; Gallick GE
    Cancer Res; 2005 May; 65(9):3664-70. PubMed ID: 15867361
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Daskalakis K; Norlén O; Karakatsanis A; Hellman P; Larsson R; Nygren P; Stålberg P
    Endocr Relat Cancer; 2018 Apr; 25(4):471-480. PubMed ID: 29440231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor effect of everolimus in preclinical models of high-grade gastroenteropancreatic neuroendocrine carcinomas.
    Bollard J; Couderc C; Blanc M; Poncet G; Lepinasse F; Hervieu V; Gouysse G; Ferraro-Peyret C; Benslama N; Walter T; Scoazec JY; Roche C
    Neuroendocrinology; 2013; 97(4):331-40. PubMed ID: 23343749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NRP-2 in tumor lymphangiogenesis and lymphatic metastasis.
    Wang J; Huang Y; Zhang J; Xing B; Xuan W; Wang H; Huang H; Yang J; Tang J
    Cancer Lett; 2018 Apr; 418():176-184. PubMed ID: 29339213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Olfactory receptor 51E1 protein as a potential novel tissue biomarker for small intestine neuroendocrine carcinomas.
    Cui T; Tsolakis AV; Li SC; Cunningham JL; Lind T; Öberg K; Giandomenico V
    Eur J Endocrinol; 2013 Feb; 168(2):253-61. PubMed ID: 23184910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropilin-1 aggravates liver cirrhosis by promoting angiogenesis via VEGFR2-dependent PI3K/Akt pathway in hepatic sinusoidal endothelial cells.
    Wang L; Feng Y; Xie X; Wu H; Su XN; Qi J; Xin W; Gao L; Zhang Y; Shah VH; Zhu Q
    EBioMedicine; 2019 May; 43():525-536. PubMed ID: 31060904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromogranin A and its fragments as regulators of small intestinal neuroendocrine neoplasm proliferation.
    Giovinazzo F; Schimmack S; Svejda B; Alaimo D; Pfragner R; Modlin I; Kidd M
    PLoS One; 2013; 8(11):e81111. PubMed ID: 24260544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropilin-2-mediated tumor growth and angiogenesis in pancreatic adenocarcinoma.
    Dallas NA; Gray MJ; Xia L; Fan F; van Buren G; Gaur P; Samuel S; Lim SJ; Arumugam T; Ramachandran V; Wang H; Ellis LM
    Clin Cancer Res; 2008 Dec; 14(24):8052-60. PubMed ID: 19088020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hedgehog inhibitor sonidegib potentiates
    Spetz J; Langen B; Rudqvist N; Parris TZ; Helou K; Nilsson O; Forssell-Aronsson E
    BMC Cancer; 2017 Aug; 17(1):528. PubMed ID: 28789624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropilin-1 in human colon cancer: expression, regulation, and role in induction of angiogenesis.
    Parikh AA; Fan F; Liu WB; Ahmad SA; Stoeltzing O; Reinmuth N; Bielenberg D; Bucana CD; Klagsbrun M; Ellis LM
    Am J Pathol; 2004 Jun; 164(6):2139-51. PubMed ID: 15161648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomics identifies neddylation as a potential therapy target in small intestinal neuroendocrine tumors.
    Fotouhi O; Kjellin H; Juhlin CC; Pan Y; Vesterlund M; Ghaderi M; Yousef A; Andersson-Sand H; Kharaziha P; Caramuta S; Kjellman M; Zedenius J; Larsson C; Orre LM
    Oncogene; 2019 Oct; 38(43):6881-6897. PubMed ID: 31406256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GNA15 expression in small intestinal neuroendocrine neoplasia: functional and signalling pathway analyses.
    Zanini S; Giovinazzo F; Alaimo D; Lawrence B; Pfragner R; Bassi C; Modlin I; Kidd M
    Cell Signal; 2015 May; 27(5):899-907. PubMed ID: 25701539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic targeting of neuropilin-2 on colorectal carcinoma cells implanted in the murine liver.
    Gray MJ; Van Buren G; Dallas NA; Xia L; Wang X; Yang AD; Somcio RJ; Lin YG; Lim S; Fan F; Mangala LS; Arumugam T; Logsdon CD; Lopez-Berestein G; Sood AK; Ellis LM
    J Natl Cancer Inst; 2008 Jan; 100(2):109-20. PubMed ID: 18182619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limitations in small intestinal neuroendocrine tumor therapy by mTor kinase inhibition reflect growth factor-mediated PI3K feedback loop activation via ERK1/2 and AKT.
    Svejda B; Kidd M; Kazberouk A; Lawrence B; Pfragner R; Modlin IM
    Cancer; 2011 Sep; 117(18):4141-54. PubMed ID: 21387274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-proliferative and anti-secretory effects of everolimus on human pancreatic neuroendocrine tumors primary cultures: is there any benefit from combination with somatostatin analogs?
    Mohamed A; Romano D; Saveanu A; Roche C; Albertelli M; Barbieri F; Brue T; Niccoli P; Delpero JR; Garcia S; Ferone D; Florio T; Moutardier V; Poizat F; Barlier A; Gerard C
    Oncotarget; 2017 Jun; 8(25):41044-41063. PubMed ID: 28454119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.